Assignee
SURFACE ONCOLOGY LLC
US·3 granted patents·4 pending applications·1 citations·filing 2019–2025
Top patents by PatentIndex Score
7 records- 0184US12162941B2Anti-CD112R compositions and methodsSURFACE ONCOLOGY LLC·Filed 2021·Granted Dec 10, 2024·1 cites·19 claims
- 0279US2025051449A1Anti-CD112R Compositions and MethodsSURFACE ONCOLOGY LLC·Filed 2024·Application pending·0 cites
- 0372US2026055176A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2025·Application pending·0 cites
- 0464US2024199732A1Anti-IL-27 Antibodies and Uses ThereofSURFACE ONCOLOGY LLC·Filed 2023·Application pending·0 cites
- 0560US2025154244A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2025·Application pending·0 cites
- 0659US12358978B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2019·Granted Jul 15, 2025·0 cites·17 claims
- 0752US12577299B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2022·Granted Mar 17, 2026·0 cites·22 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →